Increased Efficacy of Stereotactic Ablative Radiation Therapy in Combination with Bevacizumab in Lung Oligopersistent/Oligoprogressive Metastases from Colon Cancer

被引:1
|
作者
Mazzola, R. [1 ]
Levra, N. Giaj [1 ]
Ricchetti, F. [1 ]
Fersino, S. [1 ]
Fiorentino, A. [1 ]
Aiello, D. [1 ]
Alongi, F. [1 ]
机构
[1] Sacro Cuore Don Calabria Hosp, Canc Care Ctr, Div Radiat Oncol, Negrar Verona, Italy
关键词
D O I
10.1016/j.ijrobp.2017.06.1649
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3038
引用
收藏
页码:E437 / E437
页数:1
相关论文
共 50 条
  • [41] Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer
    Song, Andrew
    Lu, Bo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 657 - 660
  • [42] Stereotactic ablative body radiation therapy for isolated pulmonary metastases from pancreatic cancer after metastectomy with positive margins: a case report
    Alnsour, Anoud
    Le, Hien
    Byrne, Adam
    Rodgers, Nick
    Roos, Daniel
    JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)
  • [43] Stereotactic ablative body radiation therapy for isolated pulmonary metastases from pancreatic cancer after metastectomy with positive margins: a case report
    Anoud Alnsour
    Hien Le
    Adam Byrne
    Nick Rodgers
    Daniel Roos
    Journal of Medical Case Reports, 17
  • [44] Stereotactic Body Radiation Therapy for Lung Metastases From Colorectal Cancer: Prognostic Factors for Disease Control and Survival
    Qiu, H. C.
    Katz, A. W.
    Chowdhry, A. K.
    Usuki, K. Y.
    Singh, D. P.
    Chen, Y.
    Okunieff, P.
    Milano, M. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E400 - E400
  • [45] Case series on stereotactic body radiation therapy in primary lung cancer & metastases: early experiences from Indonesia
    Giselvania, A.
    Maubere, F.
    Kodrat, H.
    Munandar, A.
    Prajogi, G. B.
    Gondhowiardjo, S. A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1380 - S1380
  • [46] Stereotactic body radiation therapy (SBRT) for lung metastases from colorectal cancer: A single-institution experience
    Costa, S.
    Sousa, F.
    Leite-Silva, P.
    Gomes, D.
    Sousa, O.
    ANNALS OF ONCOLOGY, 2022, 33 : S313 - S314
  • [47] Results of stereotactic radiation therapy (SRT) on unique cerebral metastases from lung adenocarcinomas
    Bernardi, Marie
    Sunyach, Marie-Pierre
    Tanguy, Ronan
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [48] A Multicenter Large Retrospective Database on the Personalization of Stereotactic Ablative Radiotherapy for Lung Metastases From Colon-Rectal Cancer: The LaIT-SABR Study
    Nicosia, L.
    Franceschini, D.
    Perrone, F.
    Casamassima, F.
    Gerardi, M. A.
    Perna, M.
    Scotti, V.
    Fodor, A.
    Mazzola, R.
    Rigo, M.
    Iurato, A.
    Pasqualetti, F.
    Chiesa, S.
    Niespolo, R. M.
    Bruni, A.
    Frassinelli, L.
    Borghetti, P.
    Di Marzo, A.
    Ravasio, A.
    De Bari, B.
    Sepulcri, M.
    Aiello, D.
    Mortellaro, G.
    Sangalli, C.
    Franceschini, M.
    Montesi, G.
    Aquilanti, F. M.
    Valdagni, R.
    Fazio, I.
    Corti, L.
    Vavassori, L.
    Maranzano, E.
    Magrini, S.
    Lohr, F.
    Arcangeli, S.
    Valentini, V.
    Paiar, F.
    Ramella, S.
    Di Muzio, N. G.
    Livi, L.
    Jereczek-Fossa, B. A.
    Osti, M. F.
    Scorsetti, M.
    Alongi, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E65 - E66
  • [49] MRI-guided stereotactic ablative radiation therapy for liver metastasis from pancreatic cancer
    Hama, Yukihiro
    Tate, Etsuko
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (09) : S489 - S491
  • [50] Oligoprogressive castration-resistant prostate cancer treated with metastases-directed stereotactic body radiation therapy: predictive factors for patients' selection
    Franzese, Ciro
    Perrino, Matteo
    Marzo, Marco Antonio
    Badalamenti, Marco
    Baldaccini, Davide
    D'Agostino, Giuseppe
    Marini, Beatrice
    De Vincenzo, Fabio
    Zucali, Paolo Andrea
    Scorsetti, Marta
    CLINICAL & EXPERIMENTAL METASTASIS, 2022, 39 (03) : 449 - 457